Synthetic Lethality Is a Novel and Potential Paradigm for Precision Medicine in Advanced Hepatocellular Carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Synthetic Lethality Is a Novel and Potential Paradigm for Precision Medicine in Advanced Hepatocellular Carcinoma ; volume:9 ; number:2 ; year:2020 ; pages:225-226
Liver cancer ; 9, Heft 2 (2020), 225-226
- Urheber
-
Chen, Mingyu
Cai, Xiujun
- DOI
-
10.1159/000503927
- URN
-
urn:nbn:de:101:1-2020043000194321172148
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Mingyu
- Cai, Xiujun
Ähnliche Objekte (12)
Modeling synthetic lethality
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
Synthetic lethality in lung cancer and translation to clinical therapies
Development of synthetic lethality in cancer: molecular and cellular classification
Modeling synthetic lethality
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
Synthetic lethality in lung cancer and translation to clinical therapies
Development of synthetic lethality in cancer: molecular and cellular classification
Modeling synthetic lethality
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
Synthetic lethality in lung cancer and translation to clinical therapies